The global Blood Glucose Test Strips Market size was valued at USD 12.35 billion in 2021, and it is projected to grow at a CAGR of 6.1% during the forecast period. Factors such as the increasing prevalence of type-2 diabetes worldwide, rising demand for home blood glucose monitoring systems, and the shift from traditional venipuncture blood sugar tests to easy-to-use test kits are expected to drive market growth.

Additionally, the growing prevalence of diabetes-related diseases and the increasing awareness of early disease detection and preventive measures are contributing to the adoption of blood glucose test strips among diabetic patients, further fueling market growth.

Get a free sample PDF of the report, visit @ https://www.reportsanddata.com/download-free-sample/2398

Blood glucose test strips, when used with glucometers, allow individuals to keep track of their blood glucose levels, which plays a vital role in preventing diabetic hypoglycemia and other potential health issues. The prevalence of diabetes worldwide has been rapidly rising, with around 537 million adults diagnosed with diabetes in 2021, and this number is expected to increase to 643 million by 2030. Managing and preventing diabetes involves significant medical expenses, and it is estimated that the global GDP will suffer losses of USD 1.7 trillion from 2011 to 2030 due to the direct and indirect costs associated with diabetes treatment and care.

Key players in the Blood Glucose Test Strips Market:

• Abbott Laboratories
• Hoffmann-La Roche Ltd.
• Agamatrix
• Ascensia Diabetes Care Holdings AG
• LifeScan, Inc.
• ARKRAY, Inc.
• Medtronic plc
• Bionime Corporation
• Care Touch LLC
• DarioHealth Corporation

Consumables, including blood glucose test strips, account for around 90% of the total revenue in the self-monitoring blood glucose (SMBG) market. Test strips are preferred over continuous glucose monitoring systems due to their ease of use, convenience, minimally invasive nature, and the absence of surgical procedures for blood glucose level testing.

The global blood glucose test strips market is driven by the increasing prevalence of type-2 diabetes, which is influenced by factors such as weight gain, obesity, family history, sedentary lifestyle, and limited physical activity. Long-term diabetes can lead to cardiovascular diseases, neurological problems, and kidney damage. The number of diabetic patients has been rising steadily, with an increase from 366 million in 2011 to 536 million in 2021.

To know more about the latest insights of the report, visit @

https://www.reportsanddata.com/request-latest-insight/2398

Cardiovascular diseases account for approximately 17.9 million deaths annually, and regular monitoring of blood sugar levels can help reduce mortality rates. Test kits, including glucometers and test strips, enable convenient blood sugar level checks. Hypoglycemia, characterized by blood glucose levels below 70mg/dL, can be controlled through regular monitoring.

Nephropathy, or End-Stage Renal Disease (ESRD), is frequently associated with diabetes and can be treated by controlling diabetes and high blood pressure. The global incidence of kidney failure is increasing, driving the adoption of blood glucose test strips. Diabetic Ketoacidosis (DKA) is a life-threatening disease resulting from glucose deficiency, and SMBG devices, particularly test strips, help patients manage their blood glucose levels and avoid potential severity.

However, the finger-prick requirement for glucose testing on test strips can cause reluctance among some patients. The strips have short expiry periods, cannot be reused, and are sensitive to changes in temperature, sample quality, and humidity. The high cost of test strips adds to the financial burden on patients. These factors may hamper market revenue growth to some extent.

The COVID-19 pandemic had a significant impact on the blood glucose test strips market, with supply chain disruptions and a slump in demand. However, the market has recovered as medical equipment industries resumed production, and supply chains have resumed operations. Unhealthy lifestyle habits during the pandemic led to an unchecked increase in blood glucose levels among individuals, driving the preference for SMBG devices. Additionally, the development of a COVID-19 test kit based on test strip-operated glucometers has increased the demand for test strips. COVID-19 patients have shown a higher prevalence of diabetes, further boosting the demand for blood glucose test strips.

Request a customized copy of the report @ https://www.reportsanddata.com/request-customization-form/2398

Thank you for reading our report. To inquire about customization or any query about the report, please get in touch with us. Our team will make sure the report is best suited to your needs.  

Browse for more reports:

Head and Neck Squamous Cell Carcinoma Treatment Market - https://www.reportsanddata.com/report-detail/head-and-neck-squamous-cell-carcinoma-treatment-market

Pheochromocytoma Market - https://www.reportsanddata.com/report-detail/pheochromocytoma-market

Polyangiitis Market - https://www.reportsanddata.com/report-detail/polyangiitis-market

Impaired Glucose Tolerance Treatment Market - https://www.reportsanddata.com/report-detail/impaired-glucose-tolerance-treatment-market

Peripheral Artery Disease Treatment Market - https://www.reportsanddata.com/report-detail/peripheral-artery-disease-treatment-market

About Reports and Data 

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behaviour shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Contact Us:

John W

(Head of Business Development)

Reports and Data | Web: www.reportsanddata.com

Direct Line: +1-212-710-1370

E-mail: sales@reportsanddata.com

Blogs | Press Release | Industry News | Our competencies

Browse More Upcoming Reports @ https://www.reportsanddata.com/upcoming-reports

Browse More Latest Reports @ https://www.reportsanddata.com/report